The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 9
- 9 new
- Median first-year cost
- $692,917
- $6,481,752 in all
- Institutions
- 8
- 9 contact PIs
Awards by fiscal year
0
0
6
3
0
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- YALE UNIVERSITY2
- BAYLOR COLLEGE OF MEDICINE1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- GEORGE WASHINGTON UNIVERSITY1
- OREGON HEALTH & SCIENCE UNIVERSITY1
and 3 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 GRB-P (J1))6
- Special Emphasis Panel (ZCA1 SRB-2 (J4))3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2017 | (PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer1R01CA206483-01A1 | Emu, BrindaKaech, Susan M | YALE UNIVERSITY, CT | First-year cost $718,958 | Study section ZCA1 |
| FY2017 | (PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa1R01CA217138-01 | Phipps, WarrenWarren, Edus Houston | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | First-year cost $644,421 | Study section ZCA1 |
| FY2017 | HIV, HERV-K and Human Cancer1R01CA206275-01A1 | Hammarskjold, Marie-LouiseRekosh, David M | UNIVERSITY OF VIRGINIA, VA | First-year cost $401,250 | Study section ZCA1 |
| FY2016 | Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.1R01CA206404-01 | Wong, Scott W | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $1,368,756 | Study section ZCA1 |
| FY2016 | (PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years1R01CA206477-01 | Palefsky, Joel Michael | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $787,905 | Study section ZCA1 |
| FY2016 | (PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection1R01CA206476-01 | Chiao, Elizabeth Y. | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $772,521 | Study section ZCA1 |
| FY2016 | HIV integration-mediated modulation of immune regulation in HPV-associated cancers1R01CA206466-01 | Casper, CoreyFrenkel, Lisa M | SEATTLE CHILDREN'S HOSPITAL, WA | First-year cost $692,917 | Study section ZCA1 |
| FY2016 | (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer1R01CA206465-01 | Justice, Amy CarolineLo Re, Vincent | YALE UNIVERSITY, CT | First-year cost $563,374 | Study section ZCA1 |
| FY2016 | HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers1R01CA206488-01 | Nixon, Douglas F | GEORGE WASHINGTON UNIVERSITY, DC | First-year cost $531,650 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.